Breaking News

Covance, Merck Finalize Strategic Pact


Covance has closed its transaction with Merck to provide genomics analysis services under a five-year contract valued at $145 million.

Covance has closed its transaction with Merck to provide genomics analysis services under a five-year contract valued at $145 million. Covance has acquired Merck’s gene expression lab in Seattle, WA, and as of August 17th, assumed control of the facility and took on Merck’s Seattle employees.

Sign up today for Contracting & Outsourcing 2009!
contractpharma.com/2009conference

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters